

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of MHC class I biosynthetic process (GO:0045343) | 8.76708052 |
| 2 | natural killer cell activation involved in immune response (GO:0002323) | 8.02655199 |
| 3 | B cell proliferation (GO:0042100) | 7.24195209 |
| 4 | vocalization behavior (GO:0071625) | 7.01877228 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 6.91024408 |
| 6 | startle response (GO:0001964) | 6.74224284 |
| 7 | regulation of penile erection (GO:0060405) | 6.57082793 |
| 8 | B cell receptor signaling pathway (GO:0050853) | 6.22220335 |
| 9 | type I interferon signaling pathway (GO:0060337) | 5.84960639 |
| 10 | cellular response to type I interferon (GO:0071357) | 5.84960639 |
| 11 | response to type I interferon (GO:0034340) | 5.74703199 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.72042476 |
| 13 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.68519577 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.58578777 |
| 15 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.51566370 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 5.41743076 |
| 17 | positive regulation of humoral immune response (GO:0002922) | 5.27621050 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.26420562 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.25040696 |
| 20 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.13299810 |
| 21 | locomotory exploration behavior (GO:0035641) | 5.07366152 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.01172917 |
| 23 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.97820518 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 4.96304869 |
| 25 | presynaptic membrane assembly (GO:0097105) | 4.96160097 |
| 26 | succinate metabolic process (GO:0006105) | 4.94154954 |
| 27 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.88582888 |
| 28 | synaptic vesicle exocytosis (GO:0016079) | 4.80171386 |
| 29 | negative regulation of catecholamine secretion (GO:0033604) | 4.75277993 |
| 30 | neurotransmitter secretion (GO:0007269) | 4.72179977 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.67342240 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.63903844 |
| 33 | postsynaptic membrane organization (GO:0001941) | 4.62692619 |
| 34 | positive regulation of synapse maturation (GO:0090129) | 4.57995237 |
| 35 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.50597146 |
| 36 | protein localization to synapse (GO:0035418) | 4.48655219 |
| 37 | presynaptic membrane organization (GO:0097090) | 4.44823466 |
| 38 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.40404796 |
| 39 | positive regulation of synapse assembly (GO:0051965) | 4.39070510 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.35847097 |
| 41 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.31484865 |
| 42 | regulation of synapse maturation (GO:0090128) | 4.26548705 |
| 43 | B cell mediated immunity (GO:0019724) | 4.21260115 |
| 44 | neuron recognition (GO:0008038) | 4.20501740 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 4.19824648 |
| 46 | post-embryonic morphogenesis (GO:0009886) | 4.16310125 |
| 47 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.11773043 |
| 48 | negative regulation of cell killing (GO:0031342) | 4.11773043 |
| 49 | exploration behavior (GO:0035640) | 4.10907872 |
| 50 | regulation of action potential (GO:0098900) | 4.09992546 |
| 51 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.03229242 |
| 52 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.03229242 |
| 53 | B cell homeostasis (GO:0001782) | 4.01587474 |
| 54 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.01342489 |
| 55 | negative regulation of T cell mediated immunity (GO:0002710) | 4.00395761 |
| 56 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.99911814 |
| 57 | neuron-neuron synaptic transmission (GO:0007270) | 3.98528524 |
| 58 | protein-cofactor linkage (GO:0018065) | 3.98014641 |
| 59 | lymphocyte proliferation (GO:0046651) | 3.96698834 |
| 60 | negative thymic T cell selection (GO:0045060) | 3.91520097 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.90803670 |
| 62 | mononuclear cell proliferation (GO:0032943) | 3.90096330 |
| 63 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.88010406 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.87415849 |
| 65 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.81436901 |
| 66 | transferrin transport (GO:0033572) | 3.81423825 |
| 67 | glycine transport (GO:0015816) | 3.77277177 |
| 68 | positive regulation of antigen processing and presentation (GO:0002579) | 3.76609413 |
| 69 | negative regulation of amine transport (GO:0051953) | 3.76116988 |
| 70 | neuronal action potential propagation (GO:0019227) | 3.75508251 |
| 71 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.74751877 |
| 72 | NIK/NF-kappaB signaling (GO:0038061) | 3.72316537 |
| 73 | negative regulation of norepinephrine secretion (GO:0010700) | 3.70613721 |
| 74 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70328636 |
| 75 | neurotransmitter transport (GO:0006836) | 3.68465148 |
| 76 | cellular response to interferon-beta (GO:0035458) | 3.67229624 |
| 77 | positive regulation of action potential (GO:0045760) | 3.66718287 |
| 78 | response to cocaine (GO:0042220) | 3.66369312 |
| 79 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.64803186 |
| 80 | T cell migration (GO:0072678) | 3.63007254 |
| 81 | long-term memory (GO:0007616) | 3.62883394 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 3.62816608 |
| 83 | response to exogenous dsRNA (GO:0043330) | 3.59925103 |
| 84 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.59720596 |
| 85 | defense response to protozoan (GO:0042832) | 3.56954543 |
| 86 | trivalent inorganic cation transport (GO:0072512) | 3.56904058 |
| 87 | ferric iron transport (GO:0015682) | 3.56904058 |
| 88 | negative T cell selection (GO:0043383) | 3.55838348 |
| 89 | regulation of B cell differentiation (GO:0045577) | 3.55075735 |
| 90 | synaptic transmission, glutamatergic (GO:0035249) | 3.54053630 |
| 91 | leukocyte proliferation (GO:0070661) | 3.52596982 |
| 92 | glutamate receptor signaling pathway (GO:0007215) | 3.51709198 |
| 93 | positive regulation of type 2 immune response (GO:0002830) | 3.49326307 |
| 94 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.48846265 |
| 95 | detection of bacterium (GO:0016045) | 3.47932413 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.47477302 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.47477302 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 3.47477302 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 3.47477302 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 3.47477302 |
| 101 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.47477302 |
| 102 | axonal fasciculation (GO:0007413) | 3.46320855 |
| 103 | positive regulation of interferon-alpha production (GO:0032727) | 3.45408603 |
| 104 | positive regulation of amino acid transport (GO:0051957) | 3.45090647 |
| 105 | regulation of synapse assembly (GO:0051963) | 3.44582889 |
| 106 | aggressive behavior (GO:0002118) | 3.42960361 |
| 107 | response to histamine (GO:0034776) | 3.42515121 |
| 108 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.42397258 |
| 109 | regulation of neurotransmitter levels (GO:0001505) | 3.41435333 |
| 110 | glutamate secretion (GO:0014047) | 3.41168133 |
| 111 | detection of calcium ion (GO:0005513) | 3.40977801 |
| 112 | long-term synaptic potentiation (GO:0060291) | 3.39392774 |
| 113 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.38237965 |
| 114 | regulation of synaptic vesicle transport (GO:1902803) | 3.38114896 |
| 115 | transmission of nerve impulse (GO:0019226) | 3.36738980 |
| 116 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.36710345 |
| 117 | activated T cell proliferation (GO:0050798) | 3.34759031 |
| 118 | regulation of B cell proliferation (GO:0030888) | 3.34502091 |
| 119 | behavioral response to nicotine (GO:0035095) | 3.33869267 |
| 120 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.31306210 |
| 121 | negative regulation of viral genome replication (GO:0045071) | 3.30148327 |
| 122 | negative regulation of type 2 immune response (GO:0002829) | 3.29908196 |
| 123 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29907921 |
| 124 | neurotransmitter biosynthetic process (GO:0042136) | 3.29810883 |
| 125 | positive regulation of B cell proliferation (GO:0030890) | 3.26376876 |
| 126 | T cell activation involved in immune response (GO:0002286) | 3.25913049 |
| 127 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.25478809 |
| 128 | macrophage activation involved in immune response (GO:0002281) | 3.24809028 |
| 129 | synapse assembly (GO:0007416) | 3.24732248 |
| 130 | adaptive immune response (GO:0002250) | 3.24569066 |
| 131 | thymic T cell selection (GO:0045061) | 3.24387161 |
| 132 | response to protozoan (GO:0001562) | 3.24162255 |
| 133 | cellular response to exogenous dsRNA (GO:0071360) | 3.24158251 |
| 134 | positive thymic T cell selection (GO:0045059) | 3.23267239 |
| 135 | regulation of interferon-alpha production (GO:0032647) | 3.22426016 |
| 136 | regulation of type 2 immune response (GO:0002828) | 3.21964174 |
| 137 | response to interferon-beta (GO:0035456) | 3.21090353 |
| 138 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.20195704 |
| 139 | learning (GO:0007612) | 3.19104819 |
| 140 | negative regulation of mast cell activation (GO:0033004) | 3.17419450 |
| 141 | female mating behavior (GO:0060180) | 3.13594853 |
| 142 | cellular response to interferon-gamma (GO:0071346) | 3.13396018 |
| 143 | detection of other organism (GO:0098543) | 3.13150745 |
| 144 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.12820810 |
| 145 | dicarboxylic acid catabolic process (GO:0043649) | 3.09332956 |
| 146 | synaptic vesicle maturation (GO:0016188) | 3.08530140 |
| 147 | regulation of feeding behavior (GO:0060259) | 3.08396802 |
| 148 | righting reflex (GO:0060013) | 3.07010352 |
| 149 | cellular response to ammonium ion (GO:0071242) | 3.06131762 |
| 150 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.05531363 |
| 151 | serotonin receptor signaling pathway (GO:0007210) | 3.05296282 |
| 152 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.05077168 |
| 153 | auditory behavior (GO:0031223) | 3.04849684 |
| 154 | multicellular organismal reproductive behavior (GO:0033057) | 3.04675446 |
| 155 | intraspecies interaction between organisms (GO:0051703) | 3.03669360 |
| 156 | social behavior (GO:0035176) | 3.03669360 |
| 157 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.03445100 |
| 158 | maternal behavior (GO:0042711) | 3.02681635 |
| 159 | response to dsRNA (GO:0043331) | 3.02010687 |
| 160 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.00947396 |
| 161 | positive regulation of membrane potential (GO:0045838) | 3.00903852 |
| 162 | natural killer cell activation (GO:0030101) | 3.00856286 |
| 163 | chaperone-mediated protein transport (GO:0072321) | 2.99714835 |
| 164 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.98778141 |
| 165 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.98360751 |
| 166 | multi-organism behavior (GO:0051705) | 2.98231495 |
| 167 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.97621330 |
| 168 | cerebellar granule cell differentiation (GO:0021707) | 2.96499008 |
| 169 | proline transport (GO:0015824) | 2.96292970 |
| 170 | behavioral defense response (GO:0002209) | 2.96248890 |
| 171 | behavioral fear response (GO:0001662) | 2.96248890 |
| 172 | negative regulation of dendrite development (GO:2000171) | 2.95737184 |
| 173 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.94272238 |
| 174 | layer formation in cerebral cortex (GO:0021819) | 2.93185080 |
| 175 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93093704 |
| 176 | T cell costimulation (GO:0031295) | 2.92656603 |
| 177 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.92412529 |
| 178 | positive regulation of protein homooligomerization (GO:0032464) | 2.92253536 |
| 179 | membrane hyperpolarization (GO:0060081) | 2.91610872 |
| 180 | positive regulation of B cell activation (GO:0050871) | 2.91243879 |
| 181 | regulation of glutamate secretion (GO:0014048) | 2.90386171 |
| 182 | dendritic spine morphogenesis (GO:0060997) | 2.90079745 |
| 183 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.89587397 |
| 184 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.89543365 |
| 185 | lymphocyte costimulation (GO:0031294) | 2.88340762 |
| 186 | B cell activation (GO:0042113) | 2.87441740 |
| 187 | lymphocyte homeostasis (GO:0002260) | 2.85676287 |
| 188 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.85408160 |
| 189 | T-helper 1 type immune response (GO:0042088) | 2.82615533 |
| 190 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.81722649 |
| 191 | positive regulation of B cell mediated immunity (GO:0002714) | 2.81722649 |
| 192 | T cell selection (GO:0045058) | 2.80359948 |
| 193 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.79178357 |
| 194 | positive regulation of neutrophil migration (GO:1902624) | 2.79178357 |
| 195 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.77898535 |
| 196 | negative regulation of bone resorption (GO:0045779) | 2.76381962 |
| 197 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.75833905 |
| 198 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.75661964 |
| 199 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 10.2958257 |
| 200 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 10.2958257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 9.08097247 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.82096905 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.45743270 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.53706676 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.16638883 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.15139258 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.97937319 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.53067456 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.50815462 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.27486545 |
| 11 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.17947569 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.13549379 |
| 13 | CIITA_25753668_ChIP-Seq_RAJI_Human | 3.05553999 |
| 14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98866913 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94588125 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92098319 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.65906714 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.60017473 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.56473048 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51456176 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50971599 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48179531 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48125348 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47944807 |
| 25 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45366824 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.43784792 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.42535173 |
| 28 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.39778814 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.33273371 |
| 30 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.33273371 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 2.31345750 |
| 32 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.30352168 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.29199445 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18103547 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15868031 |
| 36 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.15036431 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.11090098 |
| 38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11000772 |
| 39 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.10666117 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.09776659 |
| 41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.07111280 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.06132514 |
| 43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.04268516 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.02895988 |
| 45 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.95635418 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.95062368 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.94678064 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93702072 |
| 49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92508549 |
| 50 | MYB_26560356_Chip-Seq_TH1_Human | 1.90670116 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.90595627 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.90349219 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.88110399 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85604618 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83547151 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83139054 |
| 57 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80786245 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.80025415 |
| 59 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.75474421 |
| 60 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75267242 |
| 61 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73748887 |
| 62 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.73195299 |
| 63 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.71004905 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69793751 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66665881 |
| 66 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65478390 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62662320 |
| 68 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.60912721 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.60248778 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57516443 |
| 71 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55941330 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55647751 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.54710069 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.53296302 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.53234302 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52612735 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.51352983 |
| 78 | MAF_26560356_Chip-Seq_TH2_Human | 1.48095036 |
| 79 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42575073 |
| 80 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41049983 |
| 81 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40579048 |
| 82 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40277281 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39551379 |
| 84 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.39279294 |
| 85 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37895040 |
| 86 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36848980 |
| 87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36695329 |
| 88 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35599393 |
| 89 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35156707 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.34918022 |
| 91 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.33938955 |
| 92 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.33623948 |
| 93 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33340451 |
| 94 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32842262 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28528822 |
| 96 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25396528 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.25132944 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.24971813 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24592479 |
| 100 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23462559 |
| 101 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21471466 |
| 102 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.21345558 |
| 103 | JUN_21703547_ChIP-Seq_K562_Human | 1.21314703 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21119225 |
| 105 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21065967 |
| 106 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.20911824 |
| 107 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20538915 |
| 108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19582505 |
| 109 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.19076160 |
| 110 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.19026424 |
| 111 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17854560 |
| 112 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.17038482 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16016328 |
| 114 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.13773984 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12446747 |
| 116 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11822214 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.11560198 |
| 118 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11269792 |
| 119 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11128367 |
| 120 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11023282 |
| 121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09351466 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08228807 |
| 123 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08157897 |
| 124 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.08041500 |
| 125 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06646179 |
| 126 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06097393 |
| 127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05928774 |
| 128 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05847805 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05140404 |
| 130 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04525807 |
| 131 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.03244112 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02835817 |
| 133 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01767425 |
| 134 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01057785 |
| 135 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01057785 |
| 136 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99293605 |
| 137 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98806295 |
| 138 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.97673307 |
| 139 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.97288286 |
| 140 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96519552 |
| 141 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96173876 |
| 142 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96123578 |
| 143 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94793882 |
| 144 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94583824 |
| 145 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.94466449 |
| 146 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94031446 |
| 147 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93511376 |
| 148 | AR_19668381_ChIP-Seq_PC3_Human | 0.93152546 |
| 149 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.93067987 |
| 150 | KDM2B_26808549_Chip-Seq_REH_Human | 0.93064499 |
| 151 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92708718 |
| 152 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92564247 |
| 153 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92044061 |
| 154 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91873854 |
| 155 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90905898 |
| 156 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90821685 |
| 157 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88279459 |
| 158 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85367440 |
| 159 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84412711 |
| 160 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84212257 |
| 161 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.80516486 |
| 162 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79764381 |
| 163 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79737057 |
| 164 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76087367 |
| 165 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.74945898 |
| 166 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.74847451 |
| 167 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.74398088 |
| 168 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.72344254 |
| 169 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72320044 |
| 170 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.70864366 |
| 171 | P300_27268052_Chip-Seq_Bcells_Human | 0.69313658 |
| 172 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68480617 |
| 173 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.67318121 |
| 174 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65588358 |
| 175 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.65120375 |
| 176 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65058124 |
| 177 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.64388891 |
| 178 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.64372395 |
| 179 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.64349895 |
| 180 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.63646778 |
| 181 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.62955097 |
| 182 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.62500835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.82752603 |
| 2 | MP0002822_catalepsy | 4.57048160 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.06591031 |
| 4 | MP0001800_abnormal_humoral_immune | 3.97292787 |
| 5 | MP0005387_immune_system_phenotype | 3.92833650 |
| 6 | MP0001790_abnormal_immune_system | 3.92833650 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 3.76495676 |
| 8 | MP0005671_abnormal_response_to | 3.69659086 |
| 9 | MP0003880_abnormal_central_pattern | 3.62897350 |
| 10 | MP0003303_peritoneal_inflammation | 3.58776893 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 3.48453174 |
| 12 | MP0009046_muscle_twitch | 3.40695185 |
| 13 | MP0000685_abnormal_immune_system | 3.36295805 |
| 14 | MP0002735_abnormal_chemical_nociception | 3.23455543 |
| 15 | * MP0009745_abnormal_behavioral_response | 3.19037269 |
| 16 | MP0002064_seizures | 3.10721266 |
| 17 | MP0005000_abnormal_immune_tolerance | 3.01638527 |
| 18 | MP0001188_hyperpigmentation | 2.96869948 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.88146007 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.86935025 |
| 21 | MP0002063_abnormal_learning/memory/cond | 2.86314863 |
| 22 | MP0002723_abnormal_immune_serum | 2.76311315 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.69656143 |
| 24 | MP0009785_altered_susceptibility_to | 2.63293719 |
| 25 | MP0002420_abnormal_adaptive_immunity | 2.59775681 |
| 26 | MP0003724_increased_susceptibility_to | 2.55766578 |
| 27 | MP0001819_abnormal_immune_cell | 2.53115692 |
| 28 | MP0001968_abnormal_touch/_nociception | 2.52364414 |
| 29 | MP0001486_abnormal_startle_reflex | 2.44170554 |
| 30 | MP0002272_abnormal_nervous_system | 2.42457726 |
| 31 | MP0005646_abnormal_pituitary_gland | 2.41243910 |
| 32 | MP0003122_maternal_imprinting | 2.40737595 |
| 33 | MP0001348_abnormal_lacrimal_gland | 2.30552986 |
| 34 | MP0001529_abnormal_vocalization | 2.28078059 |
| 35 | MP0005025_abnormal_response_to | 2.26590999 |
| 36 | MP0006276_abnormal_autonomic_nervous | 2.26583199 |
| 37 | MP0002398_abnormal_bone_marrow | 2.24811221 |
| 38 | MP0002736_abnormal_nociception_after | 2.19622415 |
| 39 | MP0001986_abnormal_taste_sensitivity | 2.15500096 |
| 40 | MP0000716_abnormal_immune_system | 2.12236250 |
| 41 | MP0003787_abnormal_imprinting | 2.10721911 |
| 42 | MP0010386_abnormal_urinary_bladder | 2.09985912 |
| 43 | MP0001984_abnormal_olfaction | 2.00090238 |
| 44 | MP0002184_abnormal_innervation | 1.95707785 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.94577931 |
| 46 | MP0002419_abnormal_innate_immunity | 1.90656929 |
| 47 | MP0001970_abnormal_pain_threshold | 1.89295298 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.88243739 |
| 49 | MP0005310_abnormal_salivary_gland | 1.88093430 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.85147415 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.84645700 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.83833167 |
| 53 | MP0000778_abnormal_nervous_system | 1.81469892 |
| 54 | * MP0002734_abnormal_mechanical_nocicepti | 1.81097700 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.80288849 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.80268104 |
| 57 | MP0003763_abnormal_thymus_physiology | 1.79343491 |
| 58 | MP0002733_abnormal_thermal_nociception | 1.78634714 |
| 59 | MP0004270_analgesia | 1.72313548 |
| 60 | MP0001873_stomach_inflammation | 1.67873683 |
| 61 | MP0003436_decreased_susceptibility_to | 1.67205764 |
| 62 | MP0009780_abnormal_chondrocyte_physiolo | 1.66266429 |
| 63 | MP0004142_abnormal_muscle_tone | 1.63845614 |
| 64 | MP0002429_abnormal_blood_cell | 1.62439421 |
| 65 | MP0001440_abnormal_grooming_behavior | 1.61164693 |
| 66 | MP0005386_behavior/neurological_phenoty | 1.60379141 |
| 67 | MP0004924_abnormal_behavior | 1.60379141 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.60058431 |
| 69 | MP0006082_CNS_inflammation | 1.58652881 |
| 70 | MP0005645_abnormal_hypothalamus_physiol | 1.58013826 |
| 71 | MP0002722_abnormal_immune_system | 1.49456825 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.46573550 |
| 73 | MP0000013_abnormal_adipose_tissue | 1.45971604 |
| 74 | MP0008569_lethality_at_weaning | 1.38773510 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.38284549 |
| 76 | MP0004811_abnormal_neuron_physiology | 1.37444980 |
| 77 | MP0001905_abnormal_dopamine_level | 1.30998446 |
| 78 | MP0003646_muscle_fatigue | 1.30894985 |
| 79 | MP0002166_altered_tumor_susceptibility | 1.28355368 |
| 80 | MP0003329_amyloid_beta_deposits | 1.27916713 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.27679053 |
| 82 | MP0002882_abnormal_neuron_morphology | 1.27072361 |
| 83 | MP0003121_genomic_imprinting | 1.26760020 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.25527940 |
| 85 | MP0000955_abnormal_spinal_cord | 1.23239701 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.21272293 |
| 87 | MP0003879_abnormal_hair_cell | 1.20490649 |
| 88 | MP0006292_abnormal_olfactory_placode | 1.17700579 |
| 89 | MP0003045_fibrosis | 1.17243253 |
| 90 | MP0004885_abnormal_endolymph | 1.16234140 |
| 91 | MP0005084_abnormal_gallbladder_morpholo | 1.15862008 |
| 92 | MP0002102_abnormal_ear_morphology | 1.14554385 |
| 93 | MP0000569_abnormal_digit_pigmentation | 1.14159050 |
| 94 | MP0008469_abnormal_protein_level | 1.10631544 |
| 95 | MP0000015_abnormal_ear_pigmentation | 1.10218821 |
| 96 | MP0008877_abnormal_DNA_methylation | 1.08723433 |
| 97 | MP0010155_abnormal_intestine_physiology | 1.07856343 |
| 98 | MP0001963_abnormal_hearing_physiology | 1.07362067 |
| 99 | MP0001502_abnormal_circadian_rhythm | 1.05457071 |
| 100 | MP0002405_respiratory_system_inflammati | 1.03329494 |
| 101 | MP0004742_abnormal_vestibular_system | 1.00333904 |
| 102 | MP0001177_atelectasis | 0.99612965 |
| 103 | MP0002152_abnormal_brain_morphology | 0.99530507 |
| 104 | MP0000026_abnormal_inner_ear | 0.98560953 |
| 105 | MP0003718_maternal_effect | 0.97229479 |
| 106 | MP0001270_distended_abdomen | 0.96728550 |
| 107 | MP0003123_paternal_imprinting | 0.95883995 |
| 108 | MP0001663_abnormal_digestive_system | 0.95123928 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.95030827 |
| 110 | MP0002069_abnormal_eating/drinking_beha | 0.94374287 |
| 111 | MP0005670_abnormal_white_adipose | 0.93247972 |
| 112 | MP0003866_abnormal_defecation | 0.93030869 |
| 113 | MP0003938_abnormal_ear_development | 0.92872165 |
| 114 | MP0000604_amyloidosis | 0.91628456 |
| 115 | MP0001664_abnormal_digestion | 0.90008895 |
| 116 | MP0009333_abnormal_splenocyte_physiolog | 0.88912656 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.88819439 |
| 118 | MP0002752_abnormal_somatic_nervous | 0.88440214 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.88408591 |
| 120 | MP0002928_abnormal_bile_duct | 0.87726321 |
| 121 | MP0005499_abnormal_olfactory_system | 0.86913521 |
| 122 | MP0005394_taste/olfaction_phenotype | 0.86913521 |
| 123 | MP0005171_absent_coat_pigmentation | 0.86660462 |
| 124 | MP0002909_abnormal_adrenal_gland | 0.85410243 |
| 125 | MP0004085_abnormal_heartbeat | 0.83034757 |
| 126 | MP0008874_decreased_physiological_sensi | 0.82976678 |
| 127 | MP0002653_abnormal_ependyma_morphology | 0.81731788 |
| 128 | MP0000613_abnormal_salivary_gland | 0.81612501 |
| 129 | MP0006035_abnormal_mitochondrial_morpho | 0.77826927 |
| 130 | MP0005379_endocrine/exocrine_gland_phen | 0.77694349 |
| 131 | MP0002229_neurodegeneration | 0.77073667 |
| 132 | MP0003632_abnormal_nervous_system | 0.76355574 |
| 133 | MP0002693_abnormal_pancreas_physiology | 0.75452994 |
| 134 | MP0004215_abnormal_myocardial_fiber | 0.74926047 |
| 135 | MP0002139_abnormal_hepatobiliary_system | 0.74018586 |
| 136 | MP0000751_myopathy | 0.73495510 |
| 137 | MP0000566_synostosis | 0.71514722 |
| 138 | MP0002006_tumorigenesis | 0.71220285 |
| 139 | MP0002277_abnormal_respiratory_mucosa | 0.70334192 |
| 140 | MP0003631_nervous_system_phenotype | 0.69849159 |
| 141 | MP0004510_myositis | 0.69662903 |
| 142 | MP0003300_gastrointestinal_ulcer | 0.69261268 |
| 143 | MP0005253_abnormal_eye_physiology | 0.68356819 |
| 144 | MP0003385_abnormal_body_wall | 0.68327992 |
| 145 | MP0001943_abnormal_respiration | 0.67557392 |
| 146 | MP0006072_abnormal_retinal_apoptosis | 0.67542794 |
| 147 | MP0003137_abnormal_impulse_conducting | 0.65882023 |
| 148 | MP0002090_abnormal_vision | 0.65448624 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.64149743 |
| 150 | MP0008872_abnormal_physiological_respon | 0.63562599 |
| 151 | MP0002095_abnormal_skin_pigmentation | 0.63465402 |
| 152 | MP0008260_abnormal_autophagy | 0.63110106 |
| 153 | MP0000371_diluted_coat_color | 0.62177622 |
| 154 | MP0008789_abnormal_olfactory_epithelium | 0.62050676 |
| 155 | MP0001346_abnormal_lacrimal_gland | 0.62022581 |
| 156 | MP0000537_abnormal_urethra_morphology | 0.61197270 |
| 157 | MP0003183_abnormal_peptide_metabolism | 0.61064331 |
| 158 | MP0006036_abnormal_mitochondrial_physio | 0.60182286 |
| 159 | MP0010770_preweaning_lethality | 0.60030116 |
| 160 | MP0002082_postnatal_lethality | 0.60030116 |
| 161 | MP0002163_abnormal_gland_morphology | 0.59661218 |
| 162 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59084912 |
| 163 | MP0000681_abnormal_thyroid_gland | 0.58983634 |
| 164 | MP0004858_abnormal_nervous_system | 0.58065378 |
| 165 | MP0003633_abnormal_nervous_system | 0.57817030 |
| 166 | MP0000767_abnormal_smooth_muscle | 0.55469871 |
| 167 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55299902 |
| 168 | MP0003091_abnormal_cell_migration | 0.51253672 |
| 169 | MP0001533_abnormal_skeleton_physiology | 0.48967643 |
| 170 | MP0004947_skin_inflammation | 0.48061881 |
| 171 | MP0000372_irregular_coat_pigmentation | 0.46801481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 8.15957733 |
| 2 | Focal motor seizures (HP:0011153) | 7.92214657 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 7.90688439 |
| 4 | Hyperventilation (HP:0002883) | 6.43117864 |
| 5 | Febrile seizures (HP:0002373) | 6.10944343 |
| 6 | Atonic seizures (HP:0010819) | 5.93029207 |
| 7 | Epileptic encephalopathy (HP:0200134) | 5.39070674 |
| 8 | Recurrent bronchitis (HP:0002837) | 5.26294622 |
| 9 | Recurrent sinusitis (HP:0011108) | 5.16852415 |
| 10 | Meningitis (HP:0001287) | 4.92052095 |
| 11 | Cellulitis (HP:0100658) | 4.67813155 |
| 12 | Focal seizures (HP:0007359) | 4.66753281 |
| 13 | Progressive inability to walk (HP:0002505) | 4.54279850 |
| 14 | Lymphopenia (HP:0001888) | 4.51295457 |
| 15 | Vasculitis (HP:0002633) | 4.47742223 |
| 16 | Absence seizures (HP:0002121) | 4.24460193 |
| 17 | Emphysema (HP:0002097) | 4.19770818 |
| 18 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.16299125 |
| 19 | Congenital stationary night blindness (HP:0007642) | 4.13708804 |
| 20 | Papilloma (HP:0012740) | 4.04196147 |
| 21 | Verrucae (HP:0200043) | 4.04196147 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 4.00788287 |
| 23 | Chronic sinusitis (HP:0011109) | 3.89324441 |
| 24 | Dialeptic seizures (HP:0011146) | 3.86626050 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.85818693 |
| 26 | Polyphagia (HP:0002591) | 3.72653192 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.68347179 |
| 28 | Recurrent pneumonia (HP:0006532) | 3.68318185 |
| 29 | Colitis (HP:0002583) | 3.67951246 |
| 30 | IgM deficiency (HP:0002850) | 3.66669722 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 3.64190156 |
| 32 | Recurrent viral infections (HP:0004429) | 3.60138889 |
| 33 | Abnormal hair whorl (HP:0010721) | 3.56904710 |
| 34 | Osteomyelitis (HP:0002754) | 3.54746728 |
| 35 | Generalized tonic-clonic seizures (HP:0002069) | 3.52817656 |
| 36 | Broad-based gait (HP:0002136) | 3.52589078 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.45987939 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 3.42238400 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.42238400 |
| 40 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.40331122 |
| 41 | Inability to walk (HP:0002540) | 3.37925800 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 3.35490037 |
| 43 | Protruding tongue (HP:0010808) | 3.32849659 |
| 44 | Restrictive lung disease (HP:0002091) | 3.32825695 |
| 45 | Abnormality of the prostate (HP:0008775) | 3.30259960 |
| 46 | Progressive macrocephaly (HP:0004481) | 3.29978403 |
| 47 | Myokymia (HP:0002411) | 3.29305593 |
| 48 | Recurrent lower respiratory tract infections (HP:0002783) | 3.27113440 |
| 49 | Chronic otitis media (HP:0000389) | 3.25984591 |
| 50 | Gingival bleeding (HP:0000225) | 3.17434378 |
| 51 | Skin rash (HP:0000988) | 3.14425612 |
| 52 | Recurrent bacterial skin infections (HP:0005406) | 3.09144097 |
| 53 | Failure to thrive in infancy (HP:0001531) | 3.08791139 |
| 54 | IgG deficiency (HP:0004315) | 3.03639386 |
| 55 | Visual hallucinations (HP:0002367) | 3.03013927 |
| 56 | Eczematoid dermatitis (HP:0000976) | 3.02150269 |
| 57 | Poor suck (HP:0002033) | 3.01158505 |
| 58 | Spontaneous abortion (HP:0005268) | 3.00422601 |
| 59 | Gait imbalance (HP:0002141) | 2.98978610 |
| 60 | Drooling (HP:0002307) | 2.96360838 |
| 61 | Excessive salivation (HP:0003781) | 2.96360838 |
| 62 | Absent speech (HP:0001344) | 2.95452314 |
| 63 | IgA deficiency (HP:0002720) | 2.95334918 |
| 64 | Hyperthyroidism (HP:0000836) | 2.94457935 |
| 65 | Progressive cerebellar ataxia (HP:0002073) | 2.93129449 |
| 66 | Sepsis (HP:0100806) | 2.91583706 |
| 67 | Recurrent fungal infections (HP:0002841) | 2.89780129 |
| 68 | Limb dystonia (HP:0002451) | 2.84939548 |
| 69 | Medial flaring of the eyebrow (HP:0010747) | 2.84221805 |
| 70 | Narrow nasal bridge (HP:0000446) | 2.79827253 |
| 71 | Urticaria (HP:0001025) | 2.78401113 |
| 72 | Mitochondrial inheritance (HP:0001427) | 2.78016313 |
| 73 | Bronchitis (HP:0012387) | 2.75067857 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.73175700 |
| 75 | Obstructive lung disease (HP:0006536) | 2.73175700 |
| 76 | Abnormal social behavior (HP:0012433) | 2.71401297 |
| 77 | Impaired social interactions (HP:0000735) | 2.71401297 |
| 78 | Acute encephalopathy (HP:0006846) | 2.71091013 |
| 79 | Recurrent abscess formation (HP:0002722) | 2.70201065 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.66676057 |
| 81 | Epileptiform EEG discharges (HP:0011182) | 2.66082630 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.64166921 |
| 83 | Recurrent otitis media (HP:0000403) | 2.61996788 |
| 84 | Pheochromocytoma (HP:0002666) | 2.61798137 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.61455208 |
| 86 | Congenital primary aphakia (HP:0007707) | 2.61216331 |
| 87 | Abnormal eating behavior (HP:0100738) | 2.60657441 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59654691 |
| 89 | Abnormality of macrophages (HP:0004311) | 2.58266967 |
| 90 | Esotropia (HP:0000565) | 2.57436373 |
| 91 | Recurrent skin infections (HP:0001581) | 2.56127733 |
| 92 | Encephalitis (HP:0002383) | 2.52914646 |
| 93 | Hypsarrhythmia (HP:0002521) | 2.52559250 |
| 94 | Poor eye contact (HP:0000817) | 2.51397504 |
| 95 | Leukopenia (HP:0001882) | 2.47822972 |
| 96 | Pulmonary infiltrates (HP:0002113) | 2.47543016 |
| 97 | Lymphoma (HP:0002665) | 2.46856191 |
| 98 | Short tibia (HP:0005736) | 2.46584001 |
| 99 | Abnormality of the labia minora (HP:0012880) | 2.45481660 |
| 100 | B lymphocytopenia (HP:0010976) | 2.44964052 |
| 101 | Abnormality of B cell number (HP:0010975) | 2.43079227 |
| 102 | Nephrogenic diabetes insipidus (HP:0009806) | 2.42824850 |
| 103 | Abnormality of male internal genitalia (HP:0000022) | 2.41142892 |
| 104 | Blue irides (HP:0000635) | 2.41112293 |
| 105 | Joint swelling (HP:0001386) | 2.40672695 |
| 106 | Sleep apnea (HP:0010535) | 2.34451419 |
| 107 | Thickened helices (HP:0000391) | 2.33149039 |
| 108 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33008660 |
| 109 | Increased CSF lactate (HP:0002490) | 2.32520789 |
| 110 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.28849564 |
| 111 | Optic disc pallor (HP:0000543) | 2.28768661 |
| 112 | Neutropenia (HP:0001875) | 2.28211291 |
| 113 | Oligomenorrhea (HP:0000876) | 2.27114424 |
| 114 | Premature loss of primary teeth (HP:0006323) | 2.24182028 |
| 115 | Specific learning disability (HP:0001328) | 2.21549184 |
| 116 | Mutism (HP:0002300) | 2.20878034 |
| 117 | Viral hepatitis (HP:0006562) | 2.20705347 |
| 118 | Anxiety (HP:0000739) | 2.20111736 |
| 119 | Retinal dysplasia (HP:0007973) | 2.16570245 |
| 120 | Fetal akinesia sequence (HP:0001989) | 2.15401755 |
| 121 | Abnormality of salivation (HP:0100755) | 2.14338482 |
| 122 | Spastic tetraplegia (HP:0002510) | 2.12945747 |
| 123 | Truncal ataxia (HP:0002078) | 2.12437258 |
| 124 | Split foot (HP:0001839) | 2.12157757 |
| 125 | Dysdiadochokinesis (HP:0002075) | 2.11558623 |
| 126 | Genital tract atresia (HP:0001827) | 2.11228905 |
| 127 | Growth hormone deficiency (HP:0000824) | 2.10791656 |
| 128 | Amblyopia (HP:0000646) | 2.08399082 |
| 129 | Increased IgE level (HP:0003212) | 2.08010627 |
| 130 | Vaginal atresia (HP:0000148) | 2.07542416 |
| 131 | Abnormality of T cells (HP:0002843) | 2.07441150 |
| 132 | Epistaxis (HP:0000421) | 2.07389011 |
| 133 | Chronic diarrhea (HP:0002028) | 2.03704480 |
| 134 | Calf muscle hypertrophy (HP:0008981) | 2.00727126 |
| 135 | Fair hair (HP:0002286) | 1.98101070 |
| 136 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.97895605 |
| 137 | Stomatitis (HP:0010280) | 1.96472756 |
| 138 | Gaze-evoked nystagmus (HP:0000640) | 1.95576501 |
| 139 | Retrobulbar optic neuritis (HP:0100654) | 1.94634062 |
| 140 | Optic neuritis (HP:0100653) | 1.94634062 |
| 141 | Chronic hepatic failure (HP:0100626) | 1.94493415 |
| 142 | Hepatocellular necrosis (HP:0001404) | 1.94347856 |
| 143 | Synostosis involving the elbow (HP:0003938) | 1.94152163 |
| 144 | Humeroradial synostosis (HP:0003041) | 1.94152163 |
| 145 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.93513575 |
| 146 | Abnormality of binocular vision (HP:0011514) | 1.93467579 |
| 147 | Diplopia (HP:0000651) | 1.93467579 |
| 148 | Agitation (HP:0000713) | 1.92427009 |
| 149 | Lissencephaly (HP:0001339) | 1.91787025 |
| 150 | Delayed gross motor development (HP:0002194) | 1.89665505 |
| 151 | Generalized myoclonic seizures (HP:0002123) | 1.88336843 |
| 152 | Akinesia (HP:0002304) | 1.88199586 |
| 153 | Skin ulcer (HP:0200042) | 1.86439965 |
| 154 | Chest pain (HP:0100749) | 1.85810181 |
| 155 | Arthralgia (HP:0002829) | 1.82567016 |
| 156 | Hypothermia (HP:0002045) | 1.82343976 |
| 157 | Abnormal pancreas size (HP:0012094) | 1.81897616 |
| 158 | Xerostomia (HP:0000217) | 1.80800988 |
| 159 | X-linked dominant inheritance (HP:0001423) | 1.79822755 |
| 160 | Gastrointestinal infarctions (HP:0005244) | 1.79584611 |
| 161 | Generalized hypopigmentation of hair (HP:0011358) | 1.78967789 |
| 162 | Bradykinesia (HP:0002067) | 1.78395017 |
| 163 | Supranuclear gaze palsy (HP:0000605) | 1.77510166 |
| 164 | Status epilepticus (HP:0002133) | 1.77289872 |
| 165 | Severe visual impairment (HP:0001141) | 1.76329709 |
| 166 | Hemiparesis (HP:0001269) | 1.76309383 |
| 167 | Shoulder girdle muscle weakness (HP:0003547) | 1.76048442 |
| 168 | Fibular hypoplasia (HP:0003038) | 1.75701624 |
| 169 | Elevated hepatic transaminases (HP:0002910) | 1.74736018 |
| 170 | Leukodystrophy (HP:0002415) | 1.73998494 |
| 171 | Spastic tetraparesis (HP:0001285) | 1.73191928 |
| 172 | Psychosis (HP:0000709) | 1.70370890 |
| 173 | Exocrine pancreatic insufficiency (HP:0001738) | 1.69991113 |
| 174 | Poor coordination (HP:0002370) | 1.69842952 |
| 175 | Complete atrioventricular canal defect (HP:0001674) | 1.69339146 |
| 176 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.69214467 |
| 177 | Depression (HP:0000716) | 1.69074131 |
| 178 | Hypergammaglobulinemia (HP:0010702) | 1.68808071 |
| 179 | Widely spaced teeth (HP:0000687) | 1.68410063 |
| 180 | Type II lissencephaly (HP:0007260) | 1.68377135 |
| 181 | Postural instability (HP:0002172) | 1.68267146 |
| 182 | Abnormality of the pleura (HP:0002103) | 1.67413596 |
| 183 | Thrombophlebitis (HP:0004418) | 1.66195426 |
| 184 | Memory impairment (HP:0002354) | 1.65553317 |
| 185 | Gastroesophageal reflux (HP:0002020) | 1.65264105 |
| 186 | Dry hair (HP:0011359) | 1.64415490 |
| 187 | Atrioventricular canal defect (HP:0006695) | 1.64128501 |
| 188 | Conical tooth (HP:0000698) | 1.63635088 |
| 189 | Petechiae (HP:0000967) | 1.62986226 |
| 190 | Poikiloderma (HP:0001029) | 1.62908156 |
| 191 | Persistence of primary teeth (HP:0006335) | 1.60223115 |
| 192 | Glucose intolerance (HP:0000833) | 1.60208905 |
| 193 | Acute hepatic failure (HP:0006554) | 1.57747280 |
| 194 | Nasal polyposis (HP:0100582) | 1.56632095 |
| 195 | Abnormality of the common coagulation pathway (HP:0010990) | 1.56023440 |
| 196 | Increased IgM level (HP:0003496) | 1.53138547 |
| 197 | Prostate neoplasm (HP:0100787) | 1.52096555 |
| 198 | Erythema (HP:0010783) | 1.51647863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.73996296 |
| 2 | TESK2 | 4.82540830 |
| 3 | MAP4K1 | 4.48262671 |
| 4 | NTRK3 | 3.72973330 |
| 5 | MARK1 | 3.53986408 |
| 6 | MAP2K7 | 3.33238442 |
| 7 | GRK1 | 3.31634024 |
| 8 | MAP3K12 | 3.23371467 |
| 9 | CDK19 | 2.95100036 |
| 10 | MAP3K4 | 2.88138455 |
| 11 | ERBB4 | 2.82188308 |
| 12 | AKT3 | 2.65169663 |
| 13 | NTRK2 | 2.38889222 |
| 14 | IRAK4 | 2.31722333 |
| 15 | SYK | 2.25197168 |
| 16 | BLK | 2.19294440 |
| 17 | PNCK | 2.11544209 |
| 18 | MAP3K13 | 2.10778461 |
| 19 | TYK2 | 2.10479543 |
| 20 | EIF2AK3 | 2.06662064 |
| 21 | IKBKE | 2.02744848 |
| 22 | MINK1 | 1.90932485 |
| 23 | TSSK6 | 1.89479961 |
| 24 | PLK2 | 1.85067944 |
| 25 | EPHA4 | 1.84044289 |
| 26 | MAP3K10 | 1.83233554 |
| 27 | BTK | 1.81978058 |
| 28 | SIK3 | 1.75957947 |
| 29 | MAP2K4 | 1.75955788 |
| 30 | TNIK | 1.67506454 |
| 31 | MAP3K9 | 1.61486938 |
| 32 | MAPK13 | 1.53994495 |
| 33 | TBK1 | 1.53676084 |
| 34 | PRPF4B | 1.51432499 |
| 35 | ARAF | 1.47691478 |
| 36 | CDK8 | 1.42237558 |
| 37 | TAOK3 | 1.41971655 |
| 38 | CSF1R | 1.36381853 |
| 39 | MUSK | 1.34733662 |
| 40 | LYN | 1.33262130 |
| 41 | MAP3K14 | 1.31446764 |
| 42 | SIK2 | 1.30596344 |
| 43 | CCNB1 | 1.25009125 |
| 44 | PRKCG | 1.22387430 |
| 45 | PKN1 | 1.21666383 |
| 46 | JAK1 | 1.20579904 |
| 47 | STK16 | 1.19747610 |
| 48 | JAK3 | 1.19512772 |
| 49 | IKBKB | 1.19432254 |
| 50 | PRKCE | 1.18798042 |
| 51 | GRK5 | 1.17760657 |
| 52 | NME1 | 1.17477311 |
| 53 | BCR | 1.13730306 |
| 54 | PHKG1 | 1.13726794 |
| 55 | PHKG2 | 1.13726794 |
| 56 | FES | 1.11956187 |
| 57 | MAPK11 | 1.11058341 |
| 58 | TEC | 1.10766267 |
| 59 | PDK3 | 1.10166229 |
| 60 | PDK4 | 1.10166229 |
| 61 | YES1 | 1.09011767 |
| 62 | HCK | 1.08421523 |
| 63 | CDK5 | 1.08078807 |
| 64 | PIK3CG | 1.04837322 |
| 65 | FGFR4 | 1.01830010 |
| 66 | KSR2 | 1.01431845 |
| 67 | TLK1 | 1.01417479 |
| 68 | UHMK1 | 1.01233129 |
| 69 | WNK3 | 1.00271257 |
| 70 | BMPR1B | 1.00253902 |
| 71 | GRK6 | 0.99812927 |
| 72 | ERBB3 | 0.99690238 |
| 73 | ADRBK2 | 0.98632870 |
| 74 | ITK | 0.96471237 |
| 75 | CAMK2A | 0.96028032 |
| 76 | PRKCQ | 0.93905762 |
| 77 | ERN1 | 0.93859280 |
| 78 | BRAF | 0.90116466 |
| 79 | SGK223 | 0.89482613 |
| 80 | SGK494 | 0.89482613 |
| 81 | DYRK2 | 0.88529179 |
| 82 | MARK3 | 0.87353505 |
| 83 | DYRK1A | 0.86001930 |
| 84 | PAK6 | 0.84811247 |
| 85 | BMPR2 | 0.84333642 |
| 86 | SGK2 | 0.83695065 |
| 87 | KSR1 | 0.82815504 |
| 88 | MATK | 0.77006049 |
| 89 | PDK1 | 0.76407918 |
| 90 | CAMK2B | 0.74613538 |
| 91 | DAPK1 | 0.72536344 |
| 92 | LCK | 0.72060702 |
| 93 | MAPK7 | 0.70921113 |
| 94 | IRAK2 | 0.69654719 |
| 95 | CSK | 0.69108444 |
| 96 | JAK2 | 0.68059828 |
| 97 | NEK9 | 0.66462255 |
| 98 | GRK7 | 0.66224052 |
| 99 | MKNK2 | 0.65694942 |
| 100 | CSNK1G2 | 0.64691446 |
| 101 | PDK2 | 0.60005821 |
| 102 | CDK14 | 0.57970708 |
| 103 | MARK2 | 0.57601857 |
| 104 | CDK18 | 0.57552976 |
| 105 | CDC42BPA | 0.57275911 |
| 106 | CAMK2D | 0.56388175 |
| 107 | MYLK | 0.55608337 |
| 108 | CAMKK1 | 0.55148671 |
| 109 | CSNK1G3 | 0.54125834 |
| 110 | EPHA3 | 0.52755280 |
| 111 | TNK2 | 0.52740955 |
| 112 | CAMK2G | 0.50306763 |
| 113 | PRKACA | 0.50139205 |
| 114 | SIK1 | 0.50116896 |
| 115 | CDK15 | 0.49354402 |
| 116 | ROCK2 | 0.48463393 |
| 117 | NTRK1 | 0.48414691 |
| 118 | ADRBK1 | 0.48111706 |
| 119 | MAPK12 | 0.46943055 |
| 120 | CAMK1 | 0.46812235 |
| 121 | PDPK1 | 0.46700525 |
| 122 | RAF1 | 0.46106200 |
| 123 | OXSR1 | 0.45891340 |
| 124 | SGK1 | 0.44682221 |
| 125 | ACVR1B | 0.43628740 |
| 126 | MAPK4 | 0.43268671 |
| 127 | PINK1 | 0.43175838 |
| 128 | TXK | 0.43033657 |
| 129 | CSNK1A1L | 0.42824213 |
| 130 | PRKCB | 0.42072301 |
| 131 | CDK3 | 0.41618881 |
| 132 | NEK6 | 0.41568390 |
| 133 | MAP3K6 | 0.40849974 |
| 134 | PASK | 0.40076045 |
| 135 | PRKCZ | 0.39353614 |
| 136 | PLK3 | 0.39197064 |
| 137 | LIMK1 | 0.38606787 |
| 138 | CDK11A | 0.38479676 |
| 139 | LATS2 | 0.36932105 |
| 140 | FGFR3 | 0.36545786 |
| 141 | TAOK1 | 0.36483270 |
| 142 | MST4 | 0.35086914 |
| 143 | FGR | 0.34907554 |
| 144 | MAP3K1 | 0.34213574 |
| 145 | RPS6KB1 | 0.33913395 |
| 146 | RIPK4 | 0.33779312 |
| 147 | MKNK1 | 0.33760070 |
| 148 | PRKG1 | 0.33502949 |
| 149 | CSNK1A1 | 0.32416963 |
| 150 | IRAK1 | 0.32304604 |
| 151 | RPS6KA5 | 0.31790004 |
| 152 | VRK1 | 0.31538807 |
| 153 | PRKCA | 0.31450554 |
| 154 | ICK | 0.31392053 |
| 155 | PIM1 | 0.31179683 |
| 156 | ROCK1 | 0.30707412 |
| 157 | FYN | 0.30152194 |
| 158 | KIT | 0.30144395 |
| 159 | CDK4 | 0.27843092 |
| 160 | CHUK | 0.27067574 |
| 161 | PRKCD | 0.26717316 |
| 162 | CAMKK2 | 0.26638854 |
| 163 | ABL1 | 0.25186300 |
| 164 | PRKCH | 0.24349928 |
| 165 | CDK9 | 0.22411775 |
| 166 | HIPK2 | 0.22247142 |
| 167 | EIF2AK2 | 0.21866911 |
| 168 | BRD4 | 0.21728986 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.81312538 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.67467765 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.63321041 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.38494762 |
| 5 | Asthma_Homo sapiens_hsa05310 | 4.09576901 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.94161031 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.82431765 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.72285730 |
| 9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.62952115 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 3.20756916 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 3.07242333 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.03750296 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.88349257 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.77060574 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.60958819 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 2.48192845 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.45318795 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34416982 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31880521 |
| 20 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.31538561 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24185753 |
| 22 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.15892775 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 2.11469333 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09774681 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 2.01110265 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.98478980 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.96289931 |
| 28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.96188947 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95246918 |
| 30 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92444668 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.91542223 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.86659976 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.85793227 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.83043339 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.76296103 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.63882163 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.61705081 |
| 38 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.61017112 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.54630050 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.49204494 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48723866 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47874235 |
| 43 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.45927039 |
| 44 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45742311 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41092510 |
| 46 | Insulin secretion_Homo sapiens_hsa04911 | 1.39683212 |
| 47 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37287282 |
| 48 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36931334 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.33998206 |
| 50 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.31896937 |
| 51 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31547097 |
| 52 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31304061 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30351220 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28167720 |
| 55 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23414537 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23244131 |
| 57 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15465573 |
| 58 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.14503334 |
| 59 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.13088580 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.06157918 |
| 61 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05311541 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04323305 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 1.04247762 |
| 64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04192012 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.03857306 |
| 66 | Axon guidance_Homo sapiens_hsa04360 | 1.02559003 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01658965 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 1.00156017 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.98752876 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.98232138 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.97826679 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95216658 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93134978 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.92061677 |
| 75 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90083878 |
| 76 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90009278 |
| 77 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89048273 |
| 78 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88132931 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82107224 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81286285 |
| 81 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.79293265 |
| 82 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79062325 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.75677138 |
| 84 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74513628 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.71919124 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68157392 |
| 87 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67064553 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67033866 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.66430557 |
| 90 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.61163049 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59946094 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.59844115 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59357682 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57023309 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.55976725 |
| 96 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54765771 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.50532716 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49419271 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49013367 |
| 100 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48737395 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.47919802 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.47816803 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46549642 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.46412617 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44933875 |
| 106 | Melanoma_Homo sapiens_hsa05218 | 0.44018441 |
| 107 | Glioma_Homo sapiens_hsa05214 | 0.43844751 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43254845 |
| 109 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42986461 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37656817 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37597042 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36502090 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35898997 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35378348 |
| 115 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.34765591 |
| 116 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33923716 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.32448455 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31400048 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.25925012 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.25844808 |
| 121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25632593 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.24966213 |
| 123 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.24953908 |
| 124 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24766425 |
| 125 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.23542290 |
| 126 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23092095 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23044177 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.22803469 |
| 129 | Legionellosis_Homo sapiens_hsa05134 | 0.21777943 |
| 130 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21579556 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21205134 |
| 132 | Platelet activation_Homo sapiens_hsa04611 | 0.21173184 |
| 133 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.20954460 |
| 134 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.19956956 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19889295 |
| 136 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.19856834 |
| 137 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19405606 |
| 138 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.18739981 |
| 139 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17282245 |
| 140 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.17145776 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.15778469 |
| 142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14770533 |
| 143 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.14766940 |
| 144 | Proteasome_Homo sapiens_hsa03050 | 0.13650618 |
| 145 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.13498357 |
| 146 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.12884234 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.12783660 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.12353498 |
| 149 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.11452520 |
| 150 | Shigellosis_Homo sapiens_hsa05131 | 0.10509037 |
| 151 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.10441905 |
| 152 | Protein export_Homo sapiens_hsa03060 | 0.08825496 |
| 153 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08819936 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.08641865 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.08298672 |
| 156 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.06833357 |
| 157 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.06692564 |
| 158 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.06309822 |
| 159 | Colorectal cancer_Homo sapiens_hsa05210 | 0.06081813 |

